Cambridge Investment Research Advisors, Inc.

Position in LNTH — Lantheus Holdings, Inc.

CIK 1419186 FAIRFIELD, IA

Back to LNTH Full portfolio

Position in LNTH

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$5,298,198

+$101,841 QoQ

Shares Held

69,851

-10.5% QoQ

Ownership

0.107%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

8 quarters on record

Common Shares in LNTH Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Cambridge Investment Research Advisors, Inc. holds $25,629,271 across 19 Drug Manufacturers - Specialty & Generic names. LNTH ranks #1 (20.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LNTH	Lantheus Holdings, Inc. This page	69,851	$5,298,198
2	ZTS	Zoetis Inc.	30,836	$3,645,123
3	UTHR	UNITED THERAPEUTICS Corp	5,575	$3,305,863
4	TEVA	Teva Pharmaceutical Industries Ltd	95,052	$2,862,966
5	PCRX	Pacira BioSciences, Inc.	122,762	$2,774,421
6	PBH	Prestige Consumer Healthcare Inc.	45,555	$2,700,044
7	VTRS	Viatris Inc	113,737	$1,536,586
8	HIMS	Hims & Hers Health, Inc.	61,872	$1,284,462

All Filings in LNTH

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,298,198	69,851	-10.5%	Shares	Sole	2026-04-30
2025-12-31	$5,196,357	78,082	+21.4%	Shares	Sole	2026-02-05
2025-09-30	$3,300,049	64,341	+77.4%	Shares	Sole	2025-11-12
2025-06-30	$2,969,144	36,271	+598.1%	Shares	Sole	2025-07-31
2025-03-31	$507,129	5,196	+43.1%	Shares	Sole	2025-04-22
2024-12-31	$324,918	3,632	+0.7%	Shares	Sole	2025-02-14
2024-09-30	$395,978	3,608	-92.0%	Shares	Sole	2024-10-28
2024-03-31	$2,802,107	45,021	—	Shares	Sole	2024-04-24
No filing history on record for this holder in this stock.